Can talking to peers boost HIV testing among chinese sex workers?

NCT ID NCT07103525

Not yet recruiting Prevention Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test a program called INSPIRE, designed to reduce stigma and increase HIV testing among Chinese immigrant women who work in massage parlors in Queens, NYC. The program involves four one-on-one conversations with a peer advocate over six weeks, plus weekly text messages. Half of the 70 participants will receive this program, while the other half will get standard HIV prevention information. The study aims to see if the program is feasible and acceptable, and whether it leads to more HIV testing and PrEP use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral intervention: one-on-one conversations and text messages with peer advocates
What this could lead to: If successful, this could provide a scalable, community-driven approach to improve HIV prevention and wellbeing for a marginalized group.
What could go wrong: This is a small pilot study (70 participants) testing feasibility, not effectiveness. Results may not generalize to other populations or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV PREVENTION WELLBEING

Contacts and locations

Locations

CUNY-Hunter College

New York, New York, 10065, United States
Columbia University Irving Medical Center

New York, New York, 10032, United States
NYU Langone Health

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.